X’PROCHEM participating to COVID-19 Virtual Partnering

X’PROCHEM joins COVID-19 Virtual Partnering initiative organized by Inova. With our proprietary chemical synthesis of mid-size proteins up to 400 amino acids, we may help vaccines developers to design and produce a solution providing immunity to protect humans from SARS-Cov-2 infections.

If you have mid-size protein challenges, have ideas to win the fight against COVID-19 and are interested in partnering with us, please contact us.